imatinib mesylate has been researched along with Skin Ulcer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Erfurt-Berge, C; Ronicke, M | 1 |
Appay, R; Aubert, S; Bouvier, C; Delteil, C; Macagno, N; Magis, Q; Malissen, N; Richard, MA | 1 |
Bagot, M; Battistella, M; Flageul, B; Galicier, L; Hickman, G; Isvy-Joubert, A; Petit, A | 1 |
3 other study(ies) available for imatinib mesylate and Skin Ulcer
Article | Year |
---|---|
Impaired Wound Healing with Imatinib Mesylate Therapy.
Topics: Antineoplastic Agents; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Skin Ulcer; Wound Healing | 2021 |
[Chordoma cutis, an unusual clinical presentation of a rare neoplasm: Chordoma].
Topics: Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Chordoma; Combined Modality Therapy; Contraindications, Procedure; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Paraplegia; Radiotherapy, Adjuvant; Sacrococcygeal Region; Skin Neoplasms; Skin Ulcer; Soft Tissue Neoplasms | 2018 |
[Myeloproliferative hypereosinophilic syndrome revealed by bipolar mucosal ulcerations].
Topics: Antineoplastic Agents; Benzamides; Biopsy; Bone Marrow; Diagnosis, Differential; Eosinophilia; Humans; Imatinib Mesylate; Male; Middle Aged; mRNA Cleavage and Polyadenylation Factors; Mucous Membrane; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Piperazines; Pulmonary Eosinophilia; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Skin Ulcer | 2012 |